Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis

Bibliographic Details
Main Authors:	Tong Cai, Yuanshan Cui, Shaoxia Yu, Qian Li, Zhongbao Zhou, Zhenli Gao
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-04-01
Series:	American Journal of Men's Health
Online Access:	https://doi.org/10.1177/1557988320905407

Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
by: Zhongbao Zhou, et al.
Published: (2019-03-01)

Meta-Analysis of Efficacy and Safety of Tadalafil Plus Tamsulosin Compared with Tadalafil Alone in Treating Men with Benign Prostatic Hyperplasia and Erectile Dysfunction
by: Zhongbao Zhou, et al.
Published: (2019-10-01)

Meta-Analysis of the Efficacy and Safety of Imidafenacin for Overactive Bladder Induced by Benign Prostatic Hyperplasia in Men Receiving Alpha-Blocker Therapy
by: Tong Cai, et al.
Published: (2020-12-01)

A comparative study of fixed dose of Tamsulosin with finasteride vs Tamsulosin with dutasteride in the management of benign prostatic hyperplasia
by: N K Mohanty, et al.
Published: (2006-01-01)

Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia
by: Bilal Chughtai, et al.
Published: (2012-10-01)

Fixed-dose combination therapy with dutasteride and tamsulosin in the management of benign prostatic hyperplasia
by: Konstantinos Dimitropoulos, et al.
Published: (2016-02-01)

A randomized comparative study of tamsulosin vs placebo in the treatment of benign prostatic hyperplasia
by: N K Mohanty, et al.
Published: (2003-01-01)

Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia?
by: Argirović Aleksandar, et al.
Published: (2013-01-01)

Short-term effect of tamsulosin and finasteride monotherapy and their combination on nigerian men with benign prostatic hyperplasia
by: Benjamin O Odusanya, et al.
Published: (2017-01-01)

Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients
by: Su Jin Kim, et al.
Published: (2017-03-01)

EFFECTIVENESS AND SAFETY OF THE «DE ALEX» BIO COMPLEX AS MONOTHERAPY AND IN COMBINATION WITH TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: P. A. Scheplev, et al.
Published: (2017-11-01)

Comparative evaluation of naftopidil and tamsulosin in the treatment of patients with lower urinary tract symptoms with benign prostatic hyperplasia
by: Mahavir Singh Griwan, et al.
Published: (2014-01-01)

Additive effect of oral LDD175 to tamsulosin and finasteride in a benign prostate hyperplasia rat model
by: Choi BR, et al.
Published: (2018-06-01)

Clinical significance of prostatic-urethral angulation on the treatment outcome of patients with symptomatic benign prostatic hyperplasia treated with tamsulosin hydrochloride
by: Hassan El-Tatawy, et al.
Published: (2015-09-01)

Non-interventional (observational) study of application of the tamsulosin (Proflosin®) in patients with benign prostatic hyperplasia in routine clinical practice
by: L. G. Spivak, et al.
Published: (2015-02-01)

PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
by: N. A. Avxentyev, et al.
Published: (2016-09-01)

Effect of combination treatment on patient-related outcome measures in benign prostatic hyperplasia: clinical utility of dutasteride and tamsulosin
by: Djavan B, et al.
Published: (2011-03-01)

Review of dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic hyperplasia: efficacy, safety, and patient acceptability
by: Barkin J
Published: (2011-10-01)

Non-interventional (observational) study of application of the tamsulosin (Proflosin®) in patients with benign prostatic hyperplasia in routine clinical practice
by: L. G. Spivak, et al.
Published: (2015-02-01)

EFFICACY OF TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA IN TERMS OF TRIAL WITHOUT CATHETER, A RANDOMIZED CONTROL TRIAL
by: Farhan Khan, et al.
Published: (2021-08-01)

The Authors Reply: Reply on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”
by: Su Jin Kim, et al.
Published: (2017-09-01)

Letter to the Editor: Commentary on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”
by: Bum Sik Tae, et al.
Published: (2017-09-01)

Fixed and separate combination of solifenacin and tamsulosin in urinary disorders associated with benign prostatic hyperplasia: a choice based on price and value comparison
by: A. G. Tolkushin, et al.
Published: (2019-08-01)

Health Effects of Alternate-Day Fasting in Adults: A Systematic Review and Meta-Analysis
by: Yuanshan Cui, et al.
Published: (2020-11-01)

Acupuncture for benign prostatic hyperplasia: A systematic review and meta-analysis.
by: Wei Zhang, et al.
Published: (2017-01-01)

EFIKASI TAMSULOSIN PADA BENIGN PROSTATIC HYPERPLASIA DENGAN RETENSIO URINE AKUT YANG MENJALANI TRIAL WITHOUT CATHETER
by: Khoirul Kholis, et al.
Published: (2016-11-01)

The impact of adding solifenacin to tamsulosin therapy for treatment of storage lower urinary tract symptoms owing to benign prostatic hyperplasia
by: Mohamed Elbadry, et al.
Published: (2020-12-01)

A randomized clinical trial to evaluate efficacy and safety of monotherapy with tadalafil or tamsulosin and their combination in men with benign prostatic hyperplasia
by: M. Bibi, et al.
Published: (2020-07-01)

The Effect of Combined Therapy with Tamsulosin Hydrochloride and Meloxicam in Patients with Benign Prostatic Hyperplasia Symptoms and Impact on Nocturia and Sleep Quality
by: Sacit Nuri Gorgel, et al.
Published: (2013-09-01)

A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement
by: Chenthil Perumal, et al.
Published: (2015-01-01)

Predictive value of the immediate effect of first dose of tamsulosin on lower urinary tract symptoms improvement in benign prostatic hyperplasia patients
by: Ayman Salah Moussa, et al.
Published: (2019-01-01)

Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia
by: Dimitropoulos K, et al.
Published: (2015-03-01)

Early versus late trail of catheter removal in patients with urinary retention secondary to benign prostatic hyperplasia under tamsulosin treatment
by: Salem Hassan Salem Mohamed, et al.
Published: (2018-01-01)

The Effect of Oral Tamsulosin vs. Oral Tamsulosin and Oral Isosorbide Dinitrate in Acute Urinary Retention Patients Due to Benign Prostatic Hyperplasia: A Double-Blind Clinical Trial Study
by: Iraj Golikhatir, et al.
Published: (2020-06-01)

Comparison of meloxicam, tamsulosin and combination of both drugs with 16 Fr and 20 Fr catheter on trial without catheter successfulness in patients with benign prostatic hyperplasia
by: Hasroni Fathurrahman, et al.
Published: (2018-12-01)

Benign Prostatic Hyperplasia
Published: (2015-01-01)

Benign prostatic hyperplasia
by: Ricardo L. V. Nunes, et al.

Relation of baseline prostate volume to improvement of lower urinary tract symptoms due to tamsulosin monotherapy in benign prostatic hyperplasia: An exploratory, multicenter, prospective study
by: Mahmoud Shoukry El-Adawy, et al.
Published: (2020-01-01)

Finasteride and Tamsulosin Combination in Benign Prostatic Enlargement in a Tertiary Hospital
by: Binod Bade Shrestha, et al.
Published: (2015-03-01)

Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis

Similar Items

Similar Items